4 datasets found
-
Federal
Debate: "How low should LDL cholesterol be lowered for optimum prevention of vascular disease?" Viewpoint: "Below 100 mg/dl"
U.S. Department of Health & Human Services —
Arteriosclerotic vascular disease manifests as heart disease, stroke, aortic aneurysms, and peripheral vascular disease, and is a growing problem world-wide. The... -
Federal
Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"
U.S. Department of Health & Human Services —
The importance of low-density lipoprotein (LDL) control in the management of patients at high risk of cardiovascular events is unquestionable. The major statin trials... -
Federal
LDL-cholesterol lowering effect of a generic product of simvastatin compared to simvastatin (Zocor™) in Thai hypercholesterolemic subjects – a randomized crossover study, the first report from Thailand
U.S. Department of Health & Human Services —
Background It is commonly agreed that people with a high blood LDL-cholesterol will have a higher risk of coronary artery disease (CAD) than people with low blood... -
Federal
Short-term LDL cholesterol-lowering efficacy of plant stanol esters
U.S. Department of Health & Human Services —
Background The short-term cholesterol-lowering efficacy of plant stanol esters has been open to debate, and the data from different clinical studies with...
4 datasets found